119 related articles for article (PubMed ID: 1919540)
1. A randomised controlled trial of recombinant interferon-gamma in Chinese patients with chronic hepatitis B virus infection.
Lau JY; Lai CL; Wu PC; Chung HT; Lok AS; Lin HJ
J Med Virol; 1991 Jul; 34(3):184-7. PubMed ID: 1919540
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
[TBL] [Abstract][Full Text] [Related]
4. Placebo-controlled trial of recombinant alpha 2-interferon in Chinese HBsAg-carrier children.
Lai CL; Lok AS; Lin HJ; Wu PC; Yeoh EK; Yeung CY
Lancet; 1987 Oct; 2(8564):877-80. PubMed ID: 2889081
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled trial of recombinant human interferon -alpha A for chronic active hepatitis B.
Williams SJ; Craig PI; Cooksley WG; Bye WA; Bilous M; Grierson JM; Nightingale BN; Burnett L; Hensley WJ; Batey RG
Aust N Z J Med; 1990 Feb; 20(1):9-19. PubMed ID: 2181991
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
Ruiz Moreno M; Jimenez J; Porres JC; Bartolomé J; Moreno A; Carreño V
Digestion; 1990; 45(1):26-33. PubMed ID: 2187723
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of chronic hepatitis B with interferon alpha-2b].
Baumgarten R; Müller R; Markus R; Hintsche-Kilger B; Fengler JD; Meisel H
Gastroenterol J; 1990; 50(3):124-8. PubMed ID: 2288653
[TBL] [Abstract][Full Text] [Related]
9. Prolonged (6 months) treatment of chronic hepatitis B virus infection with recombinant leukocyte A interferon.
Carreño V; Porres JC; Mora I; Bartolomé J; Bas C; Gutiez J; Cortés J; Hernández Guio C
Liver; 1987 Dec; 7(6):325-32. PubMed ID: 3437794
[TBL] [Abstract][Full Text] [Related]
10. Treatment with human gamma interferon of chronic hepatitis B: comparative study with alpha interferon.
Kakumu S; Ishikawa T; Mizokami M; Orido E; Yoshioka K; Wakita T; Yamamoto M
J Med Virol; 1991 Sep; 35(1):32-7. PubMed ID: 1940881
[TBL] [Abstract][Full Text] [Related]
11. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
12. Recombinant leucocyte interferon treatment of chronic hepatitis B. An analysis of two therapeutic trials.
Dusheiko GM; Paterson AC; Pitcher L; Kassianides C; DiBisceglie AM; Song E; Kew MC
J Hepatol; 1986; 3 Suppl 2():S199-207. PubMed ID: 3298408
[TBL] [Abstract][Full Text] [Related]
13. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
[TBL] [Abstract][Full Text] [Related]
14. Alpha-interferon therapy for chronic hepatitis B virus infection in children and Oriental patients.
Lok AS
J Gastroenterol Hepatol; 1991; 6 Suppl 1():15-7. PubMed ID: 1751798
[TBL] [Abstract][Full Text] [Related]
15. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
[TBL] [Abstract][Full Text] [Related]
16. [A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood].
Carreño V; Porres JC; Ruiz-Moreno M; Gutiez J; Bartolomé FJ
Rev Esp Enferm Dig; 1991 Jan; 79(1):24-8. PubMed ID: 2031770
[TBL] [Abstract][Full Text] [Related]
17. Interferon alfa-2b therapy in children with chronic hepatitis B.
Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
[TBL] [Abstract][Full Text] [Related]
18. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
19. A controlled study of treatment with recombinant interferon alpha in chronic hepatitis B virus infection: induction and maintenance schedules.
Carreño V; Porres JC; Mora I; Gutiez J; Quiroga JA; Ramón y Cajal S; Oliva H; Compernolle C; Bartolomé J
Antiviral Res; 1987 Oct; 8(3):125-37. PubMed ID: 3501274
[TBL] [Abstract][Full Text] [Related]
20. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
